Track Harrow- 11.875% NT REDEEM 31/12/2027 USD 25's other current assets ($14M) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (March 2026), HROWM shows a other current assets of $14M. That compares with $15M in the prior-year period — down 5.5% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, HROWM's other current assets is now $14M (was $15M) — a 5.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Harrow- 11.875% NT REDEEM 31/12/2027 USD 25 is outperforming or lagging.
Tracking HROWM's other current assets over time shows whether Harrow- 11.875% NT REDEEM 31/12/2027 USD 25 is scaling, shrinking, or reshaping that part of the business. The current reading is $14M That compares with $15M in the prior-year period — down 5.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this other current assets page, Stockcircle has Harrow- 11.875% NT REDEEM 31/12/2027 USD 25's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $14M) with ownership activity and broader fundamentals.
Harrow- 11.875% NT REDEEM 31/12/2027 USD 25's other current assets is $14M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.